FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313403413> ?p ?o ?g. }

• W4313403413 endingPage "171" @default.
• W4313403413 startingPage "171" @default.
• W4313403413 abstract "Background: Acute myeloid leukemia (AML) is “a heterogeneous disease,” defined by a wide range of genetic alterations and molecular mutations that have an effect on clinical outcomes and could be used to develop new drugs. In AML, the immune system is tricked and actively suppressed by leukemia itself and by mechanisms that leukemia picked up through further mutations under suppression of selection. Myeloblasts in Acute myeloid leukemia can evasion the naturak killer cell killing by many ways , one of the these way ,the myelocblast cells shed NKG2D soluble ligand (MIC A/B and or ULPB 1-6 ) in blood and bound to NKG2D activation receptor which lead to inhibit activation of NK cells. The Aim of Study: The aim of this study assessment of Soluble ligand (MICA and ULPB-1) in patients with AML. Patients and Methods: Thirty patients newly diagnosed as AML were enrolled in this study, 24 patients out of 30 were follow up after 14 days of tratment. after 30 days of treatment we get result of therapy. twenty healthy looking persons were considered as control subjects. We used ELISA technique to detection the level of soluble legand ( MICA and ULPB-1). Results: The study showed that in order level of sMICA, there were significant differences in AML patients at diagnosis and after 14 days of treatment in comparison to control subjects while there were no significant differences in the level of sULPB1 between AML patients at diagnosis and after 14 days of treatment in comparison to control subjects. Conclusion: This study showed that there was an elevated level of sMICA in AML patients at diagnosis and 14 days to treatment while there was no elevated level of sULPB1 in comparison to the control group." @default.
• W4313403413 created "2023-01-06" @default.
• W4313403413 creator A5009790361 @default.
• W4313403413 creator A5044878761 @default.
• W4313403413 creator A5057911787 @default.
• W4313403413 creator A5089179430 @default.
• W4313403413 date "2022-01-01" @default.
• W4313403413 modified "2023-10-14" @default.
• W4313403413 title "Assessment of soluble natural killer group 2d ligand (MHC Class I A and UL16 Binding Protein 1) in Iraqi patients with acute myeloid leukemia" @default.
• W4313403413 cites W1963731169 @default.
• W4313403413 cites W1964265426 @default.
• W4313403413 cites W1970527277 @default.
• W4313403413 cites W1980021547 @default.
• W4313403413 cites W2004191344 @default.
• W4313403413 cites W2016969330 @default.
• W4313403413 cites W2019524792 @default.
• W4313403413 cites W2082386398 @default.
• W4313403413 cites W2084411309 @default.
• W4313403413 cites W2117269475 @default.
• W4313403413 cites W2158080596 @default.
• W4313403413 cites W2168459600 @default.
• W4313403413 cites W2268340799 @default.
• W4313403413 cites W2291064421 @default.
• W4313403413 cites W2496135719 @default.
• W4313403413 cites W2559537906 @default.
• W4313403413 cites W2789337895 @default.
• W4313403413 cites W2799415594 @default.
• W4313403413 cites W2830196912 @default.
• W4313403413 cites W2917245118 @default.
• W4313403413 cites W2942855506 @default.
• W4313403413 cites W2947849947 @default.
• W4313403413 cites W2971049095 @default.
• W4313403413 cites W2972821915 @default.
• W4313403413 cites W2989601927 @default.
• W4313403413 cites W3036919729 @default.
• W4313403413 cites W3106546760 @default.
• W4313403413 cites W3151489730 @default.
• W4313403413 cites W3154104156 @default.
• W4313403413 cites W3162418611 @default.
• W4313403413 cites W4231346141 @default.
• W4313403413 cites W4232165211 @default.
• W4313403413 cites W4242982114 @default.
• W4313403413 doi "https://doi.org/10.4103/mj.mj_29_22" @default.
• W4313403413 hasPublicationYear "2022" @default.
• W4313403413 type Work @default.
• W4313403413 citedByCount "0" @default.
• W4313403413 crossrefType "journal-article" @default.
• W4313403413 hasAuthorship W4313403413A5009790361 @default.
• W4313403413 hasAuthorship W4313403413A5044878761 @default.
• W4313403413 hasAuthorship W4313403413A5057911787 @default.
• W4313403413 hasAuthorship W4313403413A5089179430 @default.
• W4313403413 hasBestOaLocation W43134034131 @default.
• W4313403413 hasConcept C126322002 @default.
• W4313403413 hasConcept C143998085 @default.
• W4313403413 hasConcept C154317977 @default.
• W4313403413 hasConcept C170627219 @default.
• W4313403413 hasConcept C202751555 @default.
• W4313403413 hasConcept C203014093 @default.
• W4313403413 hasConcept C207936829 @default.
• W4313403413 hasConcept C2778102761 @default.
• W4313403413 hasConcept C2778461978 @default.
• W4313403413 hasConcept C2778729363 @default.
• W4313403413 hasConcept C2778867473 @default.
• W4313403413 hasConcept C2779134260 @default.
• W4313403413 hasConcept C502942594 @default.
• W4313403413 hasConcept C54355233 @default.
• W4313403413 hasConcept C71924100 @default.
• W4313403413 hasConcept C86803240 @default.
• W4313403413 hasConcept C8891405 @default.
• W4313403413 hasConceptScore W4313403413C126322002 @default.
• W4313403413 hasConceptScore W4313403413C143998085 @default.
• W4313403413 hasConceptScore W4313403413C154317977 @default.
• W4313403413 hasConceptScore W4313403413C170627219 @default.
• W4313403413 hasConceptScore W4313403413C202751555 @default.
• W4313403413 hasConceptScore W4313403413C203014093 @default.
• W4313403413 hasConceptScore W4313403413C207936829 @default.
• W4313403413 hasConceptScore W4313403413C2778102761 @default.
• W4313403413 hasConceptScore W4313403413C2778461978 @default.
• W4313403413 hasConceptScore W4313403413C2778729363 @default.
• W4313403413 hasConceptScore W4313403413C2778867473 @default.
• W4313403413 hasConceptScore W4313403413C2779134260 @default.
• W4313403413 hasConceptScore W4313403413C502942594 @default.
• W4313403413 hasConceptScore W4313403413C54355233 @default.
• W4313403413 hasConceptScore W4313403413C71924100 @default.
• W4313403413 hasConceptScore W4313403413C86803240 @default.
• W4313403413 hasConceptScore W4313403413C8891405 @default.
• W4313403413 hasIssue "2" @default.
• W4313403413 hasLocation W43134034131 @default.
• W4313403413 hasOpenAccess W4313403413 @default.
• W4313403413 hasPrimaryLocation W43134034131 @default.
• W4313403413 hasRelatedWork W1973680102 @default.
• W4313403413 hasRelatedWork W1980863092 @default.
• W4313403413 hasRelatedWork W2001538452 @default.
• W4313403413 hasRelatedWork W2030677697 @default.
• W4313403413 hasRelatedWork W2034694119 @default.
• W4313403413 hasRelatedWork W2037773889 @default.
• W4313403413 hasRelatedWork W2082607788 @default.
• W4313403413 hasRelatedWork W2084863090 @default.

• next